Mimicry and deception in inflammatory bowel disease and intestinal behçet disease

Gastroenterology and Hepatology

Volumn 8, Issue 2, 2012, Pages 103-112

  Grigg, Erika L ^a   Kane, Sunanda ^b   Katz, Seymour ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MAYO CLINIC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Beh et disease; Crohn's disease; Inflammatory bowel disease; Intestinal beh et disease; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; ETANERCEPT; HEAT SHOCK PROTEIN; HLA B51 ANTIGEN; IMMUNOGLOBULIN D; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 19; INTERLEUKIN 23; MESALAZINE; SALAZOSULFAPYRIDINE; THALIDOMIDE;

ABDOMINAL PAIN; ANTIBODY BLOOD LEVEL; BACTERIAL INFECTION; BEHCET DISEASE; BLOOD VESSEL INJURY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ENDOSCOPY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; GASTROINTESTINAL HEMORRHAGE; HUMAN; PROGNOSIS; PYODERMA GANGRENOSUM; RECTUM HEMORRHAGE; REVIEW; STOMA; TREATMENT RESPONSE; TURKEY (REPUBLIC); ULCER; UVEITIS; WEIGHT REDUCTION;

EID: 84856877929     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284-1291.
2. Behçet H. Rezidivierende aphthose, durch ein virus verusachte geschwure am auge und an den genitalien. Dermatol Wochenschr. 1937;105:1152-1157.
3. Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behçet's disease. J Clin Gastroenterol. 2000;30:144-154.
4. Cheon JH, Han DS, Park JY, et al Korean IBD Study Group. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis. 2011;17:605-613.
5. Moon CM, Cheon JH, Shin JK, et al. Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings. Dig Dis Sci. 2010;55:2904-2911.
6. Cheon JH, Celik AF, Kim WH. Behçet's disease: gastrointestinal involvement. In: Yazici Y, Yazici H, eds. Behçet's Syndrome. 1st ed. New York, NY: Springer; 2010:165-188.
7. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996-1002. (Pubitemid 32990034)
8. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet. 2010;42:698-702.
9. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
10. Meguro A, Inoko H, Ota M, et al. Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis. 2010;69:747-754.
11. Smith EL, Yazici Y. Pathogenesis of Behçet's disease. UpToDate [website]. Updated February 10, 2011. http://www.uptodate.com/contents/ pathogenesis-ofbehcets-disease?source=search-result. Accessed May 4, 2011.
12. Baskan EB, Yilmaz E, Saricaoglu H, et al. Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease. Clin Exp Dermatol. 2007;32:186-190. (Pubitemid 46233026)
13. Kobayashi T, Sudo Y, Okamura S, et al. Monozygotic twins concordant for intestinal Behçet's disease. J Gastroenterol. 2005;40:421-425.
14. Soy M, Erken E, Konca K, Ozbek S. Smoking and Behçet's disease. Clin Rheumatol. 2000;19:508-509.
15. Barnes CG. History and diagnosis. In: Yazici Y, Yazici H, eds. Behçet's Syndrome. 1st ed. New York, NY: Springer; 2010:7-34.
16. Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol. 1997;24:128-132. (Pubitemid 27059870)
17. Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum. 2008;58:1539-1545. (Pubitemid 351705945)
18. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157:901-906. (Pubitemid 47583484)
19. Sayek I, Aran O, Uzunalimoglu B, Hersek E. Intestinal Behçet's disease: surgical experience in seven cases. Hepatogastroenterology. 1991;38:81-83.
20. Choi CH, Kim TI, Kim BC, et al. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course. Dis Colon Rectum. 2006;49:1849-1859. (Pubitemid 44853442)
21. Kyle SM, Yeong ML, Isbister WH, Clark SP. Beçhet's colitis: a differential diagnosis in inflammations of the large intestine. Aust N Z J Surg. 1991;61:547-550.
22. Hamza M. Proctitis in Behçet disease. Study of 6 cases [in French]. Rev Rhum Ed Fr. 1993;60:925-927.
23. Lebwohl O, Forde KA, Berdon WE, Morrison S, Challop R. Ulcerative esophagitis and colitis in a pediatric patient with Behçet's syndrome. Response to steroid therapy. Am J Gastroenterol. 1977;68:550-555.
24. Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH. Budd-Chiari syndrome associated with Behçet's disease. Gastroenterol Clin Biol. 2008;32:316-320.
25. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16:790-795. (Pubitemid 15040814)
26. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078-1080.
27. Tunç R, Uluhan A, Melikoǧlu M, Ozyazgan Y, Ozdoǧan H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome. Clin Exp Rheumatol. 2001;19(5 suppl 24):S45-S47. (Pubitemid 33730227)
28. Hatemi I, Hatemi G, Celik AF, et al. Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol. 2008;26(4 suppl 50):S91-S95.
29. Kim JH, Choi BI, Han JK, Choo SW, Han MC. Colitis in Behçet's disease: characteristics on double-contrast barium enema examination in 20 patients. Abdom Imaging. 1994;19:132-136. (Pubitemid 24090560)
30. Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behçet's disease. Inflamm Bowel Dis. 2001;7:243-249. (Pubitemid 32776518)
31. Kim JS, Lim SH, Choi IJ, et al. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy. 2000;32:635-640. (Pubitemid 30458632)
32. Kim ES, Chung WC, Lee KM, et al. A case of intestinal Behçet's disease similar to Crohn's colitis. J Korean Med Sci. 2007;22:918-922.
33. Masugi J, Matsui T, Fujimori T, Maeda S. A case of Behçet's disease with multiple longitudinal ulcers all over the colon. Am J Gastroenterol. 1994;89:778-780. (Pubitemid 24132065)
34. Köklü S, Yüksel O, Onur I, et al. Ileocolonic involvement in Behçet's disease: endoscopic and histologic evaluation. Digestion. 2010;81:214-217.
35. Hamdulay SS, Cheent K, Ghosh C, Stocks J, Ghosh S, Haskard DO. Wireless capsule endoscopy in the investigation of intestinal Behçet's syndrome. Rheumatology (Oxford). 2008;47:1231-1234. (Pubitemid 352038233)
36. Chang DK, Kim JJ, Choi H, et al. Double balloon endoscopy in small intestinal Crohn's disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc. 2007;66(3 suppl): S96-S98. (Pubitemid 47263460)
37. Lee JN, Ryu DY, Park SH, et al. The usefulness of in vitro interferon-gamma assay for differential diagnosis between intestinal tuberculosis and Crohn's disease [in Korean]. Korean J Gastroenterol. 2010;55:376-383.
38. Lee SK, Kim BK, Kim TI, Kim WH. Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings. Endoscopy. 2009;41:9-16.
39. Naganuma M, Iwao Y, Kashiwagi K, Funakoshi S, Ishii H, Hibi T. A case of Behçet's disease accompanied by colitis with longitudinal ulcers and granuloma. J Gastroenterol Hepatol. 2002;17:105-108. (Pubitemid 34304397)
40. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492-2499.
41. Goldstein SJ, Crooks DJ. Colitis in Behçet's syndrome. Two new cases. Radiology. 1978;128:321-323. (Pubitemid 8372256)
42. Koç Y, Güllü I, Akpek G, et al. Vascular involvement in Behçet's disease. J Rheumatol. 1992;19:402-410.
43. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430-434. (Pubitemid 32233013)
44. Papa A, Scaldaferri F, Danese S, et al. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Dig Dis. 2008;26:149-155. (Pubitemid 351572140)
45. Fresko I, Ugurlu S, Ozbakir F, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clin Exp Rheumatol. 2005;23(4 suppl 38): S67-S70.
46. Filik L, Biyikoǧlu I. Differentiation of Behçet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol. 2008;14:7271.
47. Shin SJ, Kim BC, Kim TI, Lee SK, Lee KH, Kim WH. Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease. Dig Dis Sci. 2011;56:812-818.
48. Ozyazgan Y, Bodaghi B. Eye disease in Behçet's syndrome. In: Yazici Y, Yazici H, eds. Behçet's Syndrome. 1st ed. New York, NY: Springer; 2010:73-94.
49. Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Beçhet's disease-review and basis for recommendations. Rheumatology (Oxford). 2007;46:736-741. (Pubitemid 47061701)
50. Mintz R, Feller ER, Bahr RL, Shah SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:135-139. (Pubitemid 38332174)
51. Nakamura T, Yagi H, Kurachi K, Suzuki S, Konno H. Intestinal Behçet's disease with pyoderma gangrenosum: a case report. World J Gastroenterol. 2006;12:979-981.
52. Park JJ, Cheon JH, Moon CM, et al. Long-term clinical outcomes after the first course of corticosteroid therapy in patients with moderate to severe intestinal Behçet's disease. Presented at Digestive Disease Week; May 1-5, 2010; New Orleans, Louisiana. Abstract W1321.
53. Sogawa M, Hosomi S, Takatsuka M, et al. Evaluation of the usefulness of azathioprine therapy in intestinal Beçhet's disease. Presented at Digestive Disease Week; May 1-5, 2010; New Orleans, Louisiana. Abstract W1332.
54. Choi IJ, Kim JS, Cha SD, et al. Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum. 2000;43:692-700. (Pubitemid 30324610)
55. Yasui K, Uchida N, Akazawa Y, et al. Thalidomide for treatment of intestinal involvement of juvenile-onset Behçet disease. Inflamm Bowel Dis. 2008;14:396-400. (Pubitemid 351441330)
56. Estrach C, Mpofu S, Moots RJ. Behçet's syndrome: response to infliximab after failure of entanercept. Rheumatology (Oxford). 2002;41:1213-1214. (Pubitemid 35203564)
57. Lee JH, Kim TN, Choi ST, et al. Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (infliximab). Korean J Intern Med. 2007;22:24-27.
58. Iwata S, Saito K, Yamaoka K, et al. Efficacy of combination therapy of anti-TNF alpha antibody infliximab and methotrexate in refractory entero-Behçet's disease. Mod Rheumatol. 2011;21:184-191.
59. Hassard PV, Binder SW, Nelson V, Vasiliauskas EA. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report. Gastroenterology. 2001;120:995-999. (Pubitemid 32193197)
60. Ju JH, Kwok SK, Seo SH, et al. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab. Clin Rheumatol. 2007;26:1383-1385. (Pubitemid 47034208)
61. Bawazeer A, Raffa LH, Nizamuddin SH. Clinical experience with adalimumab in the treatment of ocular Behçet disease. Ocul Immunol Inflamm. 2010;18:226-232.
62. Ariyachaipanich A, Berkelhammer C, Nicola H. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy. Inflamm Bowel Dis. 2009;15:1769-1771.
63. De Cassan C, De Vroey B, Dussault C, Hachulla E, Buche S, Colombel JF. Successful treatment with adalimumab in a familial case of gastrointestinal Behçet's disease. J Crohns Colitis. 2011;5:364-368.
64. Hatemi G, Hamuryudan V, Yurdakul S, et al. Efficacy and safety of TNF-alpha antagonists in the management of Behçet's syndrome: a systemic review. Presented at the ACR/ARHP Annual Scientific Meeting; October 16-21, 2009; Philadelphia, Pennsylvania. Abstract 1845.
65. Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behçet's disease. Inflamm Bowel Dis. 2011;17:1594-1602.
66. Naganuma M, Iwao Y, Inoue N, et al. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease. Am J Gastroenterol. 2000;95:2848-2851.